Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

138. Nerve cell migration disorder Disease details / Clinical trials / Drug dev / DR info /

Clinical trials : 2 / Drugs : 4 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 106

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Alpelisib
   Centre Hospitalier Universitaire Dijon
      2022   Phase 2   NCT05577754   France
Optional lumbar puncture + blood sample
   Centre Hospitalier Universitaire Dijon
      2022   Phase 2   NCT05577754   France
RLY-2608
   Relay Therapeutics, Inc.
      2025   Phase 2   NCT06789913   Australia;Belgium;Germany;Italy;Spain;United Kingdom;United States